Our Services

Advanced Cellular Therapies (CAR T)

BMT/ Stem Cell Transplantation

Immunotherapy

Targeted Therapy

Chemotherapy

Pediatric Services

(Hematology | Oncology | BMT & Cellular Therapy)

Our Strengths

Leading Medical Expertise

SunAct's team of leading oncologists delivers advanced cancer therapies, ensuring every patient receives a personalized and effective treatment plan.

Pioneering Advanced Therapies

SunAct leads the way in providing breakthrough cancer treatments to India, ensuring they are both affordable and accessible.

State-of-the-art facility

SunAct’s hospital facility offers a sterile, controlled environment with specialised isolation rooms, enabling world-class cancer facilities for Transplants, Chemotherapy, Immunotherapy, Targeted Therapy and CAR T-cell treatments, now available in India.

Co - founder, SunAct

Dr. (Prof.) Vijay Patil

Specialist in Solid Tumors & Advanced Cancer Therapies

Dr. (Prof.) Vijay Patil, MD, DM, is an oncologist specializing in solid tumors and advanced cancer therapies. With 19 years of experience, he has been dedicated to clinical practice, cellular therapies, and innovative drug development. He has authored more than 750 peer-reviewed publications in leading international journals, including the Journal of Clinical Oncology, The Lancet Global Health, Oral Oncology, Cancer, Cancer Cell, and ASCO publications.

He completed his MBBS from Grant Medical College & KEM Hospital, Mumbai, in 2006, completed his MD in Radiotherapy at PGIMER, Chandigarh, in 2009 with the Kataria Gold Medal, and earned his DM in Medical Oncology from Tata Memorial Centre, Mumbai, in 2013 with a Gold Medal.

Through his clinical expertise and research leadership at SunAct, Dr. (Prof.) Patil continues to contribute to advancements in oncology and strives to improve outcomes for patients worldwide.

Co - founder, SunAct

Dr. Ashay Karpe

Specialist in Blood Cancers & Advanced Cancer Therapies

Dr. Ashay Karpe, MD, DM, DNB, is a hemato-oncologist with 23 years of experience in cancer care, focusing on hematological malignancies, cellular therapies, and stem cell transplantation. His research has appeared in journals such as the Journal of Global Oncology, South Asian Journal of Cancer, Journal of Clinical Oncology, and eCancer Journal.

He completed his MBBS from KEM Hospital, Mumbai in 2002, followed by an MD in General Medicine from Government Medical College and Hospital, Aurangabad in 2007. He pursued a Fellowship in Clinical Hematology at Tata Medical Centre, Kolkata in 2012, earned a DM and DNB in Medical Oncology from Tata Memorial Hospital, Mumbai in 2016, graduating with a Gold Medal for excellence.

Dr. Karpe continues his practice in hemato-oncology, caring for patients with complex hematological cancers.

Send us a message

Share your details below, and we’ll reach out to you without delay.

Ensure you’re making the most informed decision.

Speak with our experienced team of oncologists to explore your treatment options and find the best path forward for your care.

Share your details below, and we’ll reach out to you without delay.

Disclaimer : We will be using this information for calling purposes only.

SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct head and neck cancer case study using TCR-p53 therapy in inoperable squamous cell carcinoma
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male